19 September 2024

Clinical research Immunotherapy

Could lowering cancer drug dose open tumours to immunotherapy?

8 February 2024

Immunotherapy Melanoma & skin cancer PBS Pharmaceuticals

Melanoma drug newly listed on PBS

8 February 2024

Breast cancer Genetics Immunotherapy

Genetic testing takes guess work out of breast cancer treatment

29 November 2023

Immunotherapy TGA

CAR T cell therapy under investigation by FDA

2 November 2023

Immunotherapy Melanoma & skin cancer Uveal melanomas

Gamechanger for metastatic uveal melanoma

22 August 2023

Immunotherapy

Tackling autoimmune disease with CAR T-cell therapy

30 November 2022

Immunotherapy Melanoma & skin cancer Rheumatic disease

Good news for melanoma patients with rheumatic toxicities

2 November 2022 SPONSORED

Cancer Immunotherapy

Immunotherapy in oesophageal cancer

5 October 2022

Colorectal cancer Immunotherapy

Neoadjuvant immunotherapy makes waves in colon cancer

21 September 2022

ESMO Immunotherapy Melanoma & skin cancer

Skin cancer immunotherapy offers less visible cure

27 July 2022

Immunosuppression

Transplant recipients with cancer might not miss out

13 July 2022

Haematology Immunotherapy Leukaemia

CAR-T cell therapy in myeloma: could it cure?

15 June 2022

ASCO Colorectal cancer Immunotherapy

Rectal cancer therapy wipes out 100% of tumours

23 March 2022

Clinical Immunotherapy

Good news for non-small-cell lung cancer patients

16 August 2021

Clinical Immunotherapy

CAR T cell therapy secures funding

5 May 2021

Clinical Clinical research Immunotherapy

Australia’s first CAR-T manufacturer

5 May 2021

Cancer genetics Clinical Immunotherapy

Can genetics influence our response to immunotherapy?